2007•PubMedRequires access

[Thrombolysis for acute ischaemic stroke].

Boris Modrau, Karsten Vestergaard, Helle K. Iversen, Anne-Mette F. Homburg, Gudrun Boysen, Grethe Andersen

Abstract

Thrombolysis is the only effective medical therapy for acute ischaemic stroke. The treatment has been approved in Europe since 2002. This article briefly summarises the pharmacological background of thrombolysis in cerebral ischaemic stroke. International experience with thrombolysis within the last decade as well as the successful implementation of thrombolysis in Denmark within the last 3 years is reviewed. Attention is drawn to new neuroradiological diagnostic techniques and future therapeutic possibilities.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Thrombolysis, Ischaemic stroke, Medicine, Stroke (engine), Acute stroke, Intensive care medicine, Cardiology, Tissue plasminogen activator